-
Autor
Al Hossain, Jubayer 1 Bjerkvig, Rolf 1 Brabek, Jan 1 Daubon, Thomas 1 Enger, Per Øyvind 1 Eskilsson, Eskil 1 Euskirchen, Philipp 1 Foerster, Sarah 1 Folk, Petr 1 Fritah, Sabrina 1 Graziani, Grazia 1 Harter, Patrick N 1 Jahedi, Roza 1 Jirik, Radovan 1 Joseph, Justin V 1 Keunen, Olivier 1 Knappskog, Stian 1 Leiss, Lina 1 Lund-Johansen, Morten 1 Miletic, Hrvoje 1
-
Pracoviště
Centre for Evolution and Cancer The Institut... 1 Department of Biomedicine University of Berg... 1 Department of Clinical Neurosciences Univers... 1 Department of Clinical Pharmacy Institute of... 1 Department of Clinical Science University of... 1 Department of Experimental Neurology Charité... 1 Department of Neurooncology University Hospi... 1 Department of Neurosurgery Haukeland Univers... 1 Department of Oncology Haukeland University ... 1 Department of Pathology Haukeland University... 1 Department of Physiology and Developmental B... 1 Department of Systems Medicine University of... 1 Edinger Intsitute Goethe University Medical ... 1 INSERM U1029 University of Bordeaux Allée Ge... 1 Institute of Scientific Instruments ASCR Brn... 1 KG Jebsen Brain Tumor Research Center Univer... 1 Neuro Clinic Haukeland University Hospital B... 1 Norlux Neuro Oncology Laboratory Department ... 1 Statistics and Computational Biology Laborat... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
-
Eskilsson, Eskil
Autor Eskilsson, Eskil Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Rosland, Gro V
Autor Rosland, Gro V Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Talasila, Krishna M
Autor Talasila, Krishna M Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Knappskog, Stian
Autor Knappskog, Stian Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Keunen, Olivier
Autor Keunen, Olivier Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Sottoriva, Andrea
Autor Sottoriva, Andrea Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Foerster, Sarah
Autor Foerster, Sarah Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Solecki, Gergely
Autor Solecki, Gergely Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Taxt, Torfinn
Autor Taxt, Torfinn Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Jirik, Radovan
Autor Jirik, Radovan Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
NLK
Free Medical Journals
od 1999 do Před 1 rokem
PubMed Central
od 1999 do Před 1 rokem
Europe PubMed Central
od 1999 do Před 1 rokem
Open Access Digital Library
od 1999-01-01
Medline Complete (EBSCOhost)
od 2004-01-01 do Před 1 rokem
PubMed
27286795
DOI
10.1093/neuonc/now113
Knihovny.cz E-zdroje
BACKGROUND: Amplification of the epidermal growth factor receptor (EGFR) and its mutant EGFRvIII are among the most common genetic alterations in glioblastoma (GBM), the most frequent and most aggressive primary brain tumor. METHODS: In the present work, we analyzed the clonal evolution of these major EGFR aberrations in a small cohort of GBM patients using a unique surgical multisampling technique. Furthermore, we overexpressed both receptors separately and together in 2 patient-derived GBM stem cell lines (GSCs) to analyze their functions in vivo in orthotopic xenograft models. RESULTS: In human GBM biopsies, we identified EGFR amplification as an early event because EGFRvIII mutations emerge from intratumoral heterogeneity later in tumor development. To investigate the biological relevance of this distinct developmental pattern, we established experimental model systems. In these models, EGFR(+) tumor cells showed activation of classical downstream signaling pathways upon EGF stimulation and displayed enhanced invasive growth without evidence of angiogenesis in vivo. In contrast, EGFRvIII(+) tumors were driven by activation of the prototypical Src family kinase c-Src that promoted VEGF secretion leading to angiogenic tumor growth. CONCLUSIONS: The presented work shows that sequential EGFR amplification and EGFRvIII mutations might represent concerted evolutionary events that drive the aggressive nature of GBM by promoting invasion and angiogenesis via distinct signaling pathways. In particular, c-SRC may be an attractive therapeutic target for tumors harboring EGFRvIII as we identified this protein specifically mediating angiogenic tumor growth downstream of EGFRvIII.
- MeSH
- analýza přežití MeSH
- erbB receptory genetika metabolismus MeSH
- glioblastom diagnostické zobrazování genetika metabolismus patologie MeSH
- invazivní růst nádoru MeSH
- lidé MeSH
- molekulární evoluce MeSH
- mozek diagnostické zobrazování patologie MeSH
- multimodální zobrazování MeSH
- mutace MeSH
- nádorové buněčné linie MeSH
- nádory mozku diagnostické zobrazování genetika metabolismus patologie MeSH
- patologická angiogeneze metabolismus MeSH
- protoonkogenní proteiny pp60(c-src) metabolismus MeSH
- upregulace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.